Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.

Carsten-Henning OhlmannMichelle JäschkePeter JaehnigSusanne KregeJürgen GschwendHeidrun RexerKerstin JunkerRoger ZillmannChristoph RüsselEva HellmisHenrik SuttmannMartin JanssenJan MarinAndreas HübnerMichael MathersJochen GleißnerMichael SchefflerSusan FeyerabendJens TelleJörg KlierMichael Stöckle

Published in: Prostate cancer and prostatic diseases (2023)

Keyphrases

phase ii
open label
clinical trial
phase iii
placebo controlled
double blind
locally advanced
study protocol
robot assisted
randomized controlled trial
rectal cancer
newly diagnosed
squamous cell carcinoma
bone marrow
chemotherapy induced